[PartnerRe logo]

[AXIS logo]

PartnerRe and AXIS:

A Global Leader in Specialty

Insurance and Reinsurance

January 26, 2015

 

 
 

Disclaimer

Important Information For Investors And Stockholders

This communication does not constitute an offer to buy or sell or the
solicitation of an offer to buy or sell any securities or a solicitation of any
vote or approval.  This communication relates to a proposed business
combination between PartnerRe Ltd. ("PartnerRe") and AXIS Capital Holdings
Limited ("AXIS").  In connection with this proposed business combination,
PartnerRe and/or AXIS may file one or more proxy statements, registration
statements, proxy statement/prospectus or other documents with the Securities
and Exchange Commission (the "SEC").  This communication is not a substitute
for any proxy statement, registration statement, proxy statement/prospectus or
other document PartnerRe and/or AXIS may file with the SEC in connection with
the proposed transaction.  INVESTORS AND SECURITY HOLDERS OF PARTNERRE AND AXIS
ARE URGED TO READ THE PROXY STATEMENT(S), REGISTRATION STATEMENT(S), PROXY
STATEMENT/PROSPECTUS AND OTHER DOCUMENTS THAT MAY BE FILED WITH THE SEC
CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY
WILL CONTAIN IMPORTANT INFORMATION. Any definitive proxy statement(s) (if and
when available) will be mailed to stockholders of PartnerRe and/or AXIS, as
applicable.  Investors and security holders will be able to obtain free copies
of these documents (if and when available) and other documents filed with the
SEC by PartnerRe and/or AXIS through the website maintained by the SEC at
http://www.sec.gov.  Copies of the documents filed with the SEC by PartnerRe
will be available free of charge on PartnerRe's internet website at
http://www.partnerre.com or by contacting PartnerRe's Investor Relations
Director by email at [email protected] or by phone at 1-441-294-5216.
Copies of the documents filed with the SEC by AXIS will be available free of
charge on AXIS' internet website at http://www.axiscapital.com or by contacting
AXIS' Investor Relations Contact by email at [email protected] or
by phone at 1-441-405-2727.

[C] 2015. PartnerRe and Axis Capital. All rights reserved. Proprietary and
confidential.

 

 
 

Disclaimer

Participants in Solicitation

PartnerRe, AXIS, their respective directors and certain of their respective
executive officers may be considered participants in the solicitation of
proxies in connection with the proposed transaction. Information about the
directors and executive officers of PartnerRe is set forth in its Annual Report
on Form 10-K for the year ended December 31, 2013, which was filed with the SEC
on February 27, 2014, its proxy statement for its 2014 annual meeting of
stockholders, which was filed with the SEC on April 1, 2014, its Quarterly
Report on Form 10-Q for the quarter ended September 30, 2014 which was filed
with the SEC on October 31, 2014 and its Current Reports on Form 8-K, which
were filed with the SEC on May 16, 2014 and March 27, 2014.  Information about
the directors and executive officers of AXIS is set forth in its Annual Report
on Form 10-K for the year ended December 31, 2013, which was filed with the SEC
on February 21, 2014, its proxy statement for its 2014 annual meeting of
stockholders, which was filed with the SEC on March 28, 2014, its Quarterly
Report on Form 10-Q for the quarter ended September 30, 2014 which was filed
with the SEC on October 31, 2014 and its Current Report on Form 8-K, which was
filed with the SEC on August 7, 2014, June 26, 2014, March 27, 2014 and
February 26, 2014.

These documents can be obtained free of charge from the sources indicated
above. Additional information regarding the participants in the proxy
solicitations and a description of their direct and indirect interests, by
security holdings or otherwise, will be contained in the proxy
statement/prospectus and other relevant materials to be filed with the SEC when
they become available.

[C] 2015. PartnerRe and Axis Capital. All rights reserved. Proprietary and
confidential.

 

 
 

Disclaimer

Forward Looking Statements

Certain statements in this communication regarding the proposed transaction
between PartnerRe and AXIS are "forward-looking" statements. The words
"anticipate," "believe," "ensure," "expect," "if," "intend," "estimate,"
"probable," "project," "forecasts," "predict," "outlook," "aim," "will,"
"could," "should," "would," "potential," "may," "might," "anticipate," "likely"
"plan," "positioned," "strategy," and similar expressions, and the negative
thereof, are intended to identify forward-looking statements. These
forward-looking statements, which are subject to risks, uncertainties and
assumptions about PartnerRe and AXIS, may include projections of their
respective future financial performance, their respective anticipated growth
strategies and anticipated trends in their respective businesses. These
statements are only predictions based on current expectations and projections
about future events. There are important factors that could cause actual
results, level of activity, performance or achievements to differ materially
from the results, level of activity, performance or achievements expressed or
implied by the forward-looking statements, including the risk factors set forth
in PartnerRe's and AXIS' most recent reports on Form 10-K, Form 10-Q and other
documents on file with the SEC and the factors given below:

* Failure to obtain the approval of shareholders of PartnerRe or AXIS in
connection with the proposed transaction;

* The failure to consummate or delay in consummating the proposed transaction
for other reasons;

* The timing to consummate the proposed transaction;

* The risk that a condition to closing of the proposed transaction may not be
satisfied;

* The risk that a regulatory approval that may be required for the proposed
transaction is delayed, is not obtained, or is obtained subject to conditions
that are not anticipated;

* AXIS' or PartnerRe's ability to achieve the synergies and value creation
contemplated by the proposed transaction;

* The ability of either PartnerRe or AXIS to effectively integrate their
businesses; and

* The diversion of management time on transaction-related issues.


PartnerRe's forward-looking statements are based on assumptions that PartnerRe
believes to be reasonable but that may not prove to be accurate. AXIS'
forward-looking statements are based on assumptions that PartnerRe believes to
be reasonable but that may not prove to be accurate. Neither PartnerRe nor AXIS
can guarantee future results, level of activity, performance or achievements.
Moreover, neither PartnerRe nor AXIS assumes responsibility for the accuracy
and completeness of any of these forward-looking statements. PartnerRe and AXIS
assume no obligation to update or revise any forward-looking statements as a
result of new information, future events or otherwise, except as may be
required by law. Readers are cautioned not to place undue reliance on these
forward-looking statements that speak only as of the date hereof.

[C] 2015. PartnerRe and Axis Capital. All rights reserved. Proprietary and
confidential.

 

 
 

A Global Leader in Specialty Insurance and Reinsurance

* Combination will be a (re)insurance powerhouse with approximately $13bn
combined shareholders equity(1)

[] Brings together two strong, world-class, successful companies building on
existing strengths

[] Transaction creates a top 5 global reinsurance franchise with leading
position in the broker channel

[] Primary specialty platform with $2.5bn+   in premiums across a diversified
array of product lines

[] Significant player in Life, Accident and Health market

* Value creation through combined franchise strengths including significant
capital efficiencies and meaningful synergies

[] Expanded ability to invest in growing specialty franchises and to return
capital to shareholders

[] Enhanced ability to partner with other capital providers to deliver value to
all stakeholders

[] Over $200  million in identifiable, actionable and concrete expense savings


[] Transaction expected to be meaningfully accretive to earnings and return on
equity

* Clear common vision accelerates strategies for both companies

[] Growth accompanied by excellence in risk management

[] Best-in-class    talent across all aspects of business

[] Compatible cultures facilitate integration

(1) Financial data as of 9/30/14.

[C] 2015. PartnerRe and Axis Capital. All rights reserved. Proprietary and
confidential.

 

 
 

A Merger of Equals: Overview

Structure

* 100% stock Merger of Equals structured as an amalgamation

* Shares in PartnerRe and AXIS to convert to new shares in the Amalgamated
company at a fixed exchange ratio

* Preferred shares to remain outstanding as preferred shares of the Amalgamated
company


Deal Value

* $11 billion pro forma market capitalization

* AXIS shareholders will receive 1 common share and PartnerRe shareholders will
receive 2.18 common shares in the amalgamated company for each share they own


Pro Forma Ownership

* PartnerRe will own approximately 51.6 percent of the amalgamated company

* AXIS will own approximately 48.4 percent of the amalgamated company


Corporate Governance of Combined Company

* Board of Directors to comprise 14 members, consisting of seven AXIS
appointees and seven PartnerRe appointees

* Management teams to reflect balance, leveraging talent from both
organizations


Approvals

* Customary regulatory approvals

* PartnerRe and AXIS shareholder approvals

* Expected close in the second half of 2015


[C] 2015. PartnerRe and Axis Capital. All rights reserved. Proprietary and
confidential.

 

 
 

World-Class Management Team

                                        Non-executive Chairman                   Jean-Paul L. Montupet, Chairman PartnerRe
-------------------------------------------------------------------------------- -------------------------------------------
                                                 Chairman Emeritus               Michael A. Butt, Chairman AXIS Capital
-------------------------------------------------------------------------------- -------------------------------------------
                                                                             CEO Albert A. Benchimol, CEO AXIS Capital
-------------------------------------------------------------------------------- -------------------------------------------
                                                                             CFO Joseph Henry, CFO AXIS Capital
-------------------------------------------------------------------------------- -------------------------------------------
       Deputy CFO and Lead Integration Officer*                                  Bill Babcock, PartnerRe CFO
-------------------------------------------------------------------------------- -------------------------------------------
                                                   CEO, Reinsurance              Emmanuel Clarke, CEO PartnerRe Global
-------------------------------------------------------------------------------- -------------------------------------------
                                                        CEO, Insurance           Peter Wilson, CEO AXIS Insurance
-------------------------------------------------------------------------------- -------------------------------------------
                               CEO, Life, Accident and Health                    Chris DiSipio, CEO AXIS Accident and Health
-------------------------------------------------------------------------------- -------------------------------------------
Head of Strategic Business Development and
                                                     Capital Solutions           John "Jay" Nichols, CEO AXIS Re

* Assuming the role of CFO no later than July, 2016

[C] 2015. PartnerRe and Axis Capital. All rights reserved. Proprietary and
confidential.


 

 
 

Building on Existing Strengths

                KEY
        CAPABILITY                       METRIC                PartnerRe                 AXIS
---------------------------- ------------------------ -------------------- --------------------
                                BVPS + Dividend
             Value Creation   growth (2002 -- 2014               13.1%                13.0%
                                   YTD growth)(1)
---------------------------- ------------------------ -------------------- --------------------
               Excellence in 2002 -- 2014YTD avg.                93.9%                87.1%
                underwriting     combined ratio(2)
---------------------------- ------------------------ -------------------- --------------------
                                                      16 of 21 years since
                Conservative   Years of favorable                          12 of 12 years since
                                                      inception and every
reserving philosophy         reserve development                                    inception
                                                          year since 2003
---------------------------- ------------------------ -------------------- --------------------
                               Total capitalization
Robust balance sheet                                            $7.8bn               $6.8bn
                                      at 9/30/14(3)
---------------------------- ------------------------ -------------------- --------------------
                                       A.M. Best                     A+                   A+
      Financial strength
                                            SandP                    A+                   A+

(1) Calculations based on diluted shares, calculated using the Treasury Stock
Method.
(2) Combined ratio of PartnerRe's Non-life  segment only. Excludes Life and
Health and certain corporate expenses.
(3) Excluding non-controlling  interests and AXIS capitalization pro forma for
$500M  of senior notes that matured in December 2014.

[C] 2015. PartnerRe and Axis Capital. All rights reserved. Proprietary and
confidential.

 

 
 

Strong Position in Three Attractive Businesses

BUSINESS OVERVIEW

[GRAPHIC OMITTED]

[C] 2015. PartnerRe and Axis Capital. All rights reserved. Proprietary and
confidential.


 

 
 

Global Reach with Opportunities for Consolidating Locations

[GRAPHIC OMITTED]

[C] 2015. PartnerRe and Axis Capital. All rights reserved. Proprietary and
confidential.

 

 
 

Transformative Combination Creating a Leading Global Reinsurance Platform

Market position

* Top 5 global reinsurer with approximately $7 billion in GPW

* Leading position among broker-based reinsurers

* Strong positions in specialty reinsurance lines

* Combination of two additive platforms with highly regarded UW and service
capabilities

* Limited overlap in current portfolios suggesting manageable attrition

* Ability to channel third-party capital to deliver expanded client solutions


Top Global PandC Reinsurers by PandC Reinsurance GPW(1)

[GRAPHIC OMITTED]

Note: Chart excludes life and health reinsurance GPW if publicly disclosed.
Excludes Lloyd's.
(1) Rankings are by 2013 GPW.
(2) Berkshire Hathaway Reinsurance includes General Re.  Corp.
(3) GPW not disclosed.  Indicated values are on a NPW basis.

[C] 2015. PartnerRe and Axis Capital. All rights reserved. Proprietary and
confidential.

 

 
 

Diversified Global Specialty Insurance Business

Pro Forma Combined Insurance Breakdown 9/30/14 LTM GPW

[GRAPHIC OMITTED]

[] Balanced portfolio mix between segments

[] Almost no business overlap in existing books

[] Optionality to further accelerate growth in desirable segments

[] Growing visibility among clients / distribution partners / talent

[] PartnerRe's DandF business complementary to insurance

[C] 2015. PartnerRe and Axis Capital. All rights reserved. Proprietary and
confidential.

 

 
 

Leadership in Life and AandH with High Growth Potential

* A leading Life, Accident and Health franchise with limited product overlap
with truly global reach


                                                     PartnerRe                                 AXIS
LTM Gross Premiums                   Life: $ 945m
                                                                      $ 278m
                           (Written) AandH: $ 256m
------------------------------------ -------------------------------- --- ---------------------------
                                     []  31% LTM GPW
                                     []  Significant recent growth in []  30% GPW CAGR since 2011
           Recent Growth                 AandH aided by Presidio
                    Highlights           acquisition                  []  Mix of 51% Insurance / 49%
                                                                          Reinsurance for 9/30/14 LTM
                                     []  Strong and stable growth in
                                         Life portfolio
------------------------------------ --- ---------------------------- --- ---------------------------
        Leading Lines of             Life Re                          Accident
                      Business       U.S. Health                      Specialty Health
                                                                      Travel
------------------------------------ --- ---------------------------- -------------------------------
                                                                      U.S.
    Geographic Reach                 U.S.                             U.K. / London Market
                                     Continental Europe               Continental Europe
                                                                      Middle East
------------------------------------ --- ---------------------------- -------------------------------


[C] 2015. PartnerRe and Axis Capital. All rights reserved. Proprietary and
confidential.

 

 
 

Combination of Two Strong Balance Sheets with Potential Capital Synergies

($ in billions)
As at 9/30/14
                                                         +
-------------------------------- ------- ------- ---------
  Cash and Investments(1)        $17.5   $15.5   $33.0
  Shareholders Equity(2)           7.0     5.8   12.8
  Total Capitalization(2)(3)       7.8     6.8   14.6
  Total Debt + Preferred / Total  21.3%   23.8%   22.4%
  Capitalization

Excludes purchase accounting adjustments and transaction fees.
(1) Includes PartnerRe's Funds Held -- Directly Managed portfolio.
(2) Excluding non-controlling  interest.
(3) Excluding non-controlling  interests and AXIS capitalization pro forma for
$500M of senior notes that matured in December 2014.

[C] 2015. PartnerRe and Axis Capital. All rights reserved. Proprietary and
confidential.

 

 
 

Tremendous Opportunity for Value Creation

* Profitable growth

[] Sustainable, long-term commercial growth prospects through combined scale,
efficiencies and expanded product capability

[] Meaningful capital synergies generating further flexibility to support
growth and capital management initiatives

* At least $200M  of annual run-rate  quantified expense synergies expected to
be realized within first 18 months operations

[] Concrete, achievable expense savings

[] Principal sources include staff redundancies, systems and infrastructure and
holding company expenses

[C] 2015. PartnerRe and Axis Capital. All rights reserved. Proprietary and
confidential.

 

 
 

Attractive Financial Implications

* Meaningfully accretive to shareholders of both companies

[] Earnings per share

[] Return on equity

* Limited execution risk of integration given:

[] Quality of both companies' balance sheets

[] Familiarity between the companies' management teams

[] Shared philosophy of underwriting conservatism

[] True merger of equals led by CEO with deep knowledge of both organizations

[C] 2015. PartnerRe and Axis Capital. All rights reserved. Proprietary and
confidential.

 

 
 

Conclusion

* Combination will be a (re)insurance powerhouse with approximately $13bn
combined shareholders equity(1)

[] Brings together two strong, world-class, successful companies building on
existing strengths

[] Transaction creates a top 5 global reinsurance franchise with leading
position in the broker channel

[] Primary specialty platform with $2.5bn+   in premiums across a diversified
array of product lines

[] Significant player in Life, Accident and Health market

* Value creation through combined franchise strengths including significant
capital efficiencies and meaningful synergies

[] Expanded ability to invest in growing specialty franchises and to return
capital to shareholders

[] Enhanced ability to partner with other capital providers to deliver value to
all stakeholders

[] Over $200  million in identifiable, actionable and concrete expense savings


[] Transaction expected to be meaningfully accretive to earnings and return on
equity

* Clear common vision accelerates strategies for both companies

[] Growth accompanied by excellence in risk management

[] Best-in-class    talent across all aspects of business

[] Compatible cultures facilitate integration

(1) Financial data as of 9/30/14.

[C] 2015. PartnerRe and Axis Capital. All rights reserved. Proprietary and
confidential.